Cho Y, Ziboh V A
Department of Dermatology, University of California, Davis 95616.
Biochem Biophys Res Commun. 1994 May 30;201(1):257-65. doi: 10.1006/bbrc.1994.1697.
13-Hydroxyoctadecadienoic acid (13-HODE) is a major lipoxygenase metabolite of linoleic acid in epidermis. Employing a docosahexaenoic acid (22:6n-3) induced model of hyperproliferative guinea pig epidermis, we demonstrated reversal of hyperproliferation by topical 13-HODE. To delineate a possible mechanism for 13-HODE effect, we demonstrated that topical 13-HODE was incorporated into 13-HODE-containing diacylglycerol (13HODE-DAG). This novel substituted-DAG which was markedly depleted in the hyperproliferative skin paralleled the increased activities of PKC-alpha and beta. Replenishment of the hyperproliferative epidermis with topical 13-HODE resulted in the accumulation of tissue 13HODE-DAG and the selective suppression of PKC-beta activity. These data taken together suggest that the generation of putative 13-HODE-DAG and the selective suppression of PKC-beta isozyme activity may play a role in modulating epidermal hyperproliferation.
13-羟基十八碳二烯酸(13-HODE)是表皮中亚油酸的主要脂氧合酶代谢产物。利用二十二碳六烯酸(22:6n-3)诱导的豚鼠表皮过度增殖模型,我们证明了局部应用13-HODE可逆转过度增殖。为了阐明13-HODE作用的可能机制,我们证明局部应用的13-HODE被整合到含13-HODE的二酰甘油(13HODE-DAG)中。这种新型的取代二酰甘油在过度增殖的皮肤中明显减少,与蛋白激酶C-α和β的活性增加平行。用局部13-HODE补充过度增殖的表皮导致组织13HODE-DAG的积累和蛋白激酶C-β活性的选择性抑制。综合这些数据表明,假定的13-HODE-DAG的产生和蛋白激酶C-β同工酶活性的选择性抑制可能在调节表皮过度增殖中起作用。